Completed PHASE3 INTERVENTIONAL NCT00057434

Vitamin A Therapy for Tuberculosis

Adjunct Vitamin A Therapy for Tuberculosis and HIV/AIDS

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions HIV Infections Pulmonary Tuberculosis

Updated 5 times since 2017 Last updated: Sep 17, 2007 Started: Sep 30, 1998

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00057434, this PHASE3 trial focuses on HIV Infections and Pulmonary Tuberculosis and remains completed. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID), it has been updated 5 times since 1998, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Allergy and Infectious Diseases (NIAID)

Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zomba, Malawi